Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202789010 | Acrivastine + pseudoephedrine hydrochlorid 8mg/60mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215642017 | Acrivastine + pseudoephedrine hydrochlorid 8mg/60mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478827017 | Acrivastine+pseudoephedrine hydrochlorid 8mg/60mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2463841014 | Acrivastine + pseudoephedrine hydrochloride 8mg/60mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2470315011 | Acrivastine+pseudoephedrine hydrochloride 8mg/60mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2767662017 | Acrivastine + pseudoephedrine hydrochloride 8mg/60mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3490504013 | Product containing acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3494335012 | Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3494336013 | Product containing acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569385018 | Product containing only acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569386017 | Product containing only acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3676272015 | Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3676273013 | Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3676274019 | Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46812801000001112 | Pseudoephedrine 60mg / Acrivastine 8mg capsules | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Product containing acrivastine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Pseudoephedrine compound product | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has active ingredient | Pseudoephedrine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has active ingredient | Acrivastine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has active ingredient | Pseudoephedrine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Acrivastine+pseudoephedrine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Product containing acrivastine and pseudoephedrine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has active ingredient | Pseudoephedrine hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has basis of strength substance | Pseudoephedrine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 60 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has active ingredient | Acrivastine | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has basis of strength substance | Acrivastine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 8 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Product containing acrivastine and pseudoephedrine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has precise active ingredient | Pseudoephedrine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has precise active ingredient | Acrivastine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Product containing only acrivastine and pseudoephedrine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Pseudoephedrine + Acrivastine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has active ingredient | Acrivastine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has active ingredient | Pseudoephedrine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | capsule.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has specific active ingredient | Acrivastine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has specific active ingredient | Pseudoephedrine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has dispensed dose form | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Benadryl Plus capsules (Pfizer Consumer Healthcare) | Is a | True | Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Pseudoephedrine 60mg / Acrivastine 8mg capsules 12 capsule | Is pack of | False | Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Pseudoephedrine 60mg / Acrivastine 8mg capsules 24 capsule | Is pack of | False | Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Pseudoephedrine 60mg / Acrivastine 8mg capsules 24 capsule | Has VMP | True | Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Pseudoephedrine 60mg / Acrivastine 8mg capsules 12 capsule | Has VMP | True | Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets